Jingzhou Hu

9PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Periodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2026
CD266+ myofibroblasts mediate resistance to immunochemotherapy through ECM stiffness in head and neck squamous cell carcinoma.

|Mar 13, 2026
Context-Dependent Role of GDF15: GDF15+ Tumor-Associated Macrophages Suppress OSCC Progression by Enhancing Phagocytosis.

Xinyu Zhou, Zhihang Zhou, Houyu Ju

|Feb 09, 2026
Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Yun Bi, Xinwei Yang, Yusheng Lu

|Jun 11, 2025
IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma.

Wenyi Yang, Zhaoyang Guo, Houyu Ju

|Feb 18, 2025
Real-World Study of Later-Line Anlotinib in R/M Head and Neck Squamous Cell Carcinoma.

Houyu Ju, Yuanyuan Zhao, Minqi Zhao

|Oct 22, 2024
Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy.

Keyong Yuan, Shengming Xu, Guanglong Liu

Pageof 2

Frequent Collaborators

3 joint publications

Guoxin Ren

2 joint publications

Haishui Sun

2 joint publications

Yuanchen Yin

2 joint publications

Wenyi Yang